MODDERN thinking

CMOs from some of the leading patient advocacy groups, acting under the auspices of the National Health Council, have spent two years crafting a legislative proposal they hope will jumpstart personalized medicine and revive promising therapies that have been abandoned because they lack adequate IP protection.

The proposed language for the Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network (MODDERN) Cures Act will be the basis for legislation to be introduced in the House as a stand-alone bill by Rep. Leonard Lance (R-N.J.). But its best prospect for enactment is to get folded into next year's PDUFA reauthorization...